- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/38 - Heterocyclic compounds having sulfur as a ring hetero atom
Patent holdings for IPC class A61K 31/38
Total number of patents in this class: 527
10-year publication summary
|
20
|
30
|
22
|
20
|
20
|
16
|
40
|
21
|
23
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2198 |
17 |
| Shire Human Genetic Therapies, Inc. | 190 |
9 |
| Merck Sharp & Dohme Corp. | 2183 |
8 |
| Flatley Discovery Lab, LLC | 19 |
7 |
| Mirum Pharmaceuticals, Inc. | 96 |
7 |
| The Regents of the University of California | 20590 |
6 |
| Gilead Sciences, Inc. | 2207 |
5 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 861 |
5 |
| Sunshine Lake Pharma Co., Ltd. | 619 |
5 |
| Merck Sharp & Dohme LLC | 3737 |
5 |
| Glaxosmithkline LLC | 529 |
4 |
| Massachusetts Institute of Technology | 10204 |
4 |
| Lumena Pharmaceuticals, Inc. | 13 |
4 |
| Satiogen Pharmaceuticals, Inc. | 12 |
4 |
| University of Notre Dame du Lac | 600 |
4 |
| Sumitomo Dainippon Pharma Oncology, Inc. | 18 |
4 |
| Sitryx Therapeutics Limited | 49 |
4 |
| Vandria SA | 17 |
4 |
| Boehringer Ingelheim International GmbH | 4494 |
3 |
| Centre National de La Recherche Scientifique | 10914 |
3 |
| Other owners | 415 |